Total Reports
187
FDA CVM filings
Dog /
FDA CVM · 2025 release 187 reports on file
Greater Swiss Mountain Dog - FDA Adverse Event Profile
Adverse-event records for Greater Swiss Mountain Dog (Dog) from the FDA Center for Veterinary Medicine.
Data updated June 2026
The record at a glance
Greater Swiss Mountain Dog's FDA record: #186 most-reported dog breed, 187 total reports, 3.2% death-coded (6 reports).
- #186
- most-reported dog breed
- 3.2%
- death-coded report share
- 31
- Vomiting - top reaction
- 4.3 yr
- average age at report
Read report counts next to breed popularity: a bigger number often just means more owners and more vet visits.
Deaths Reported
6
of 187 reports
Death Rate
3.2%
death-coded share
Avg Age at Report
4.3 yr
42.1 kg avg weight
Death-Coded Outcome Share
Greater Swiss Mountain Dog death-coded reports 3.2%
Cross-breed median
3.2% of 187 greater swiss mountain dog reports involved a death outcome.
How to read this number
Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (about 4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
Average weight at time of report: 42.1 kg (92.8 lbs)
Top Reported Reactions
Vomiting 31
Diarrhoea 19
Seizure NOS 15
Lethargy (see also Central nervous system depression in 'Neurological') 15
Lack of efficacy (endoparasite) - hookworm 13
Emesis 10
Lack of efficacy - NOS 9
Polyuria 9
Most Referenced Drugs
Milbemycin Oxime + Spinosad 24
Pyrantel Pamoate;Sarolaner 23
Milbemycin Oxime + Praziquantel 21
Moxidectin 14
Carprofen 12
Oclacitinib Maleate 12
Lufenuron + Milbemycin Oxime 11
Bedinvetmab 10
Outcome Breakdown
Ongoing
58 (34.1%)
Recovered/Normal
57 (33.5%)
Outcome Unknown
46 (27.1%)
Recovered with Sequela
3 (1.8%)
Euthanized
3 (1.8%)
Died
3 (1.8%)
Gender Distribution
Male 104 (55.6%)
Female 82 (43.9%)
Unknown 1 (0.5%)
Reports by Year
| Year | Reports | Trend |
|---|---|---|
| 2010 | 8 | |
| 2011 | 12 | |
| 2012 | 6 | |
| 2013 | 8 | |
| 2014 | 11 | |
| 2015 | 9 | |
| 2016 | 11 | |
| 2017 | 10 | |
| 2018 | 8 | |
| 2019 | 10 | |
| 2020 | 14 | |
| 2021 | 23 | |
| 2022 | 12 | |
| 2023 | 14 | |
| 2024 | 19 | |
| 2025 | 12 | |
Greater Swiss Mountain Dog Pet Health Insights
Greater Swiss Mountain Dog accounts for 187 FDA adverse event reports, ranking #186 by volume among dog breeds, with 6 reports (3.2%) coded as a death outcome. Mean age at report: 4.3 years, average weight 42.1 kg (92.8 lbs).
Top reported signs: Vomiting (31), Diarrhoea (19), Seizure NOS (15). Most-referenced drug: Milbemycin Oxime + Spinosad (24 reports), followed by Pyrantel Pamoate;Sarolaner (23) and Milbemycin Oxime + Praziquantel (21).
Outcome coding on 170 status-recorded reports is dominated by Ongoing (34.1%). Annual submissions ranged 2,010-2,025 across 16 years on file.
Dog Breeds With a Similar Report Volume
Pointer - English Pointer
179 reports · 8.9% death rate
Terrier - American Staffordshire
197 reports · 2.0% death rate
Terrier - Irish
176 reports · 2.3% death rate
Collie - Bearded
173 reports · 6.9% death rate
Foxhound (unspecified)
168 reports · 4.8% death rate
Coonhound - Redbone
210 reports · 3.8% death rate
Frequently Asked Questions
How many FDA adverse event reports involve Greater Swiss Mountain Dog? ▼
There are 187 adverse event reports involving Greater Swiss Mountain Dog in the FDA database, with 6 reports involving death (3.2% death rate). Greater Swiss Mountain Dog ranks #186 by report volume.
What are the most common adverse reactions reported for Greater Swiss Mountain Dog? ▼
The most commonly reported adverse reactions for Greater Swiss Mountain Dog are Vomiting (31 reports), Diarrhoea (19 reports), Seizure NOS (15 reports), Lethargy (see also Central nervous system depression in 'Neurological') (15 reports), Lack of efficacy (endoparasite) - hookworm (13 reports).
What drugs are most frequently associated with Greater Swiss Mountain Dog adverse events? ▼
The drugs most frequently referenced in Greater Swiss Mountain Dog adverse event reports are Milbemycin Oxime + Spinosad (24 reports), Pyrantel Pamoate;Sarolaner (23 reports), Milbemycin Oxime + Praziquantel (21 reports), Moxidectin (14 reports), Carprofen (12 reports).
What is the average age of Greater Swiss Mountain Dog in adverse event reports? ▼
The average age of Greater Swiss Mountain Dog at the time of adverse event reports is 4.3 years, with an average weight of 42.1 kg (92.8 lbs).
Does a high number of adverse event reports mean Greater Swiss Mountain Dog is unhealthy? ▼
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this Greater Swiss Mountain Dog safety data come from? ▼
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.
Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how death rate and rankings are computed.
Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. Breed figures are computed directly from FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.